ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,238Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 3734

$637K Total Retail Price of All Prescriptions

Rank: 414 out of 3734

508 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 508 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 11,856 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 1,145 846 1 3
SIMVASTATIN 1,049 801 2 1
METFORMIN HCL 835 646 3 8
OMEPRAZOLE 670 473 4 4
METOPROLOL TARTRATE 478 370 5 6
RANITIDINE HCL 470 372 6 32
LEVOTHYROXINE SODIUM 462 353 7 2
AMLODIPINE BESYLATE 441 333 8 5
ACETAMINOPHEN-CODEINE 412 229 S3 9 123
FUROSEMIDE 372 300 10 7
ZOLPIDEM TARTRATE 356 173 11 24
IBUPROFEN 341 212 12 75
VENTOLIN HFA 329 214 13 70
DIOVAN 277 188 14 31
HYDROCHLOROTHIAZIDE 251 152 15 9
NAPROXEN 231 167 16 101
LOVASTATIN 223 180 17 41
TAMSULOSIN HCL 206 206 18 29
TRICOR 196 117 19 93
SINGULAIR 189 136 20 95
CYCLOBENZAPRINE HCL 187 78 R 21 87
GLIPIZIDE 180 107 22 57
ALENDRONATE SODIUM 176 154 23 26
GLYBURIDE 174 162 R 24 64
TRAMADOL HCL 160 86 25 20
JANUVIA 158 107 26 50
CLOPIDOGREL 158 138 26 23
ISOSORBIDE MONONITRATE ER 140 114 28 34
MECLIZINE HCL 137 130 29 139
CLOTRIMAZOLE-BETAMETHASONE 136 103 30 135
ADVAIR DISKUS 132 86 31 35
HUMULIN 70-30 130 120 32 229
LANTUS SOLOSTAR 126 81 33 102
FLOVENT HFA 118 92 34 199
DIOVAN HCT 117 84 35 72
PLAVIX 116 102 36 39
PRAVASTATIN SODIUM 115 92 37 15
ATENOLOL 115 59 37 13
ATORVASTATIN CALCIUM 114 92 39 11
MONTELUKAST SODIUM 112 63 40 175
LANTUS 111 73 41 54
DONEPEZIL HCL 109 106 42 25
GLYBURIDE-METFORMIN HCL 109 88 R 42 154
ACTOS 103 81 44 110
CARVEDILOL 100 72 45 30
GABAPENTIN 100 58 45 17
FLUTICASONE PROPIONATE 99 66 47 46
ENALAPRIL MALEATE 92 83 48 63
LOSARTAN POTASSIUM 85 47 49 21
AMLODIPINE BESYLATE-BENAZEPRIL 79 67 50 56
LEVEMIR FLEXPEN 76 54 51 184
VERAPAMIL ER 76 62 51 96
INSULIN SYRINGE 74 55 53 109
GLIMEPIRIDE 74 63 53 37
UNIFINE PENTIPS 73 73 55 384
WARFARIN SODIUM 73 73 55 10
CELEBREX 72 72 57 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 47 58 27
AMOXICILLIN 58 40 59 108
SPIRIVA 57 48 60 40
SERTRALINE HCL 57 45 60 18
DIGOXIN 53 43 62 43
SINGLE USE SWAB 51 32 63 292
PROPRANOLOL HCL 51 35 63 126
DILTIAZEM 24HR CD 51 40 63 97
BETAMETHASONE DIPROPIONATE 50 33 66 285
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.